CN Patent

CN112368289B — 作为mtor抑制剂的c26-连接的雷帕霉素类似物

Assigned to Ruixin Pharmaceutical Co · Expires 2024-02-20 · 2y expired

What this patent protects

本公开文本涉及mTOR抑制剂。具体地，实施方案涉及抑制mTOR的化合物和组合物、治疗由mTOR介导的疾病的方法以及合成这些化合物的方法。

USPTO Abstract

本公开文本涉及mTOR抑制剂。具体地，实施方案涉及抑制mTOR的化合物和组合物、治疗由mTOR介导的疾病的方法以及合成这些化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112368289B
Jurisdiction
CN
Classification
—
Expires
2024-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Ruixin Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.